Umeå University's logo

umu.sePublications
Change search
Link to record
Permanent link

Direct link
Juto, Per
Alternative names
Publications (9 of 9) Show all publications
Sjöström, S., Hjalmars, U., Juto, P., Wadell, G., Hallmans, G., Tjönneland, A., . . . Melin, B. S. (2011). Human immunoglobulin G levels of viruses and associated glioma risk. Cancer Causes and Control, 22(9), 1259-1266
Open this publication in new window or tab >>Human immunoglobulin G levels of viruses and associated glioma risk
Show others...
2011 (English)In: Cancer Causes and Control, ISSN 0957-5243, E-ISSN 1573-7225, Vol. 22, no 9, p. 1259-1266Article in journal (Refereed) Published
Abstract [en]

Few consistent etiological factors have been identified for primary brain tumors. Inverse associations to asthma and low levels of varicella-zoster virus, immunoglobulin (Ig) levels in prevalent cases have indicted a role for the immune system in the development of glioma. Because samples from prevalent cases of glioma could be influenced by treatments such as steroids and chemotherapy, we investigated pre-diagnostic samples from three large Scandinavian cohorts. To test the hypothesis that immune response levels to these viruses are associated etiologically with glioma risk, we investigated pre-diagnostic immunoglobulin levels for cytomegalovirus (CMV), varicella-zoster virus (VZV), adenovirus (Ad), and Epstein-Barr virus (EBV) including the nuclear antigen (EBNA1) using plasma samples from 197 cases of adult glioma and 394 controls collected from population-based cohorts in Sweden and Denmark. Low VZV IgG levels were marginally significantly more common in glioma cases than the controls (odds ratio (OR) = 0.68, 95% CI 0.41-1.13) for the fourth compared with the first quartile (p = 0.06 for trend). These results were more prominent when analyzing cases with blood sampling at least 2 years before diagnosis (OR = 0.63, 95% CI 0.37-1.08) (p = 0.03). No association with glioma risk was observed for CMV, EBV, and adenovirus.

Place, publisher, year, edition, pages
Springer, 2011
Keywords
Glioma, Glioblastoma, Immunoglobulin G, Virus, Case–control study
National Category
Cancer and Oncology
Research subject
Oncology
Identifiers
urn:nbn:se:umu:diva-45928 (URN)10.1007/s10552-011-9799-3 (DOI)21717196 (PubMedID)2-s2.0-80052306232 (Scopus ID)
Available from: 2011-08-22 Created: 2011-08-22 Last updated: 2023-03-24Bibliographically approved
Johansson, P., Olsson, G. E., Low, H.-T., Bucht, G., Ahlm, C., Juto, P. & Elgh, F. (2008). Puumala hantavirus genetic variability in an endemic region (Northern Sweden). Infection, Genetics and Evolution, 8(3), 286-296
Open this publication in new window or tab >>Puumala hantavirus genetic variability in an endemic region (Northern Sweden)
Show others...
2008 (English)In: Infection, Genetics and Evolution, ISSN 1567-1348, E-ISSN 1567-7257, Vol. 8, no 3, p. 286-296Article in journal (Refereed) Published
Abstract [en]

Puumala hantavirus (PUUV), naturally harboured and shed by bank voles (Myodes [Clethrionomys] glareolus), is the etiological agent to nephropathia epidemica (NE), a mild haemorrhagic fever with renal syndrome. Both host and virus are found throughout much of the European continent and in northern Sweden NE is the second most prevalent serious febrile viral infection after influenza. The reliability of diagnostics by PCR depends on genetic variability for the detection of viral nucleic acids in unknown samples. In the present study we evaluated the genetic variability of PUUV isolated from bank voles in an area of northern Sweden highly endemic for NE. Genetic variability among bank voles was also investigated to evaluate co-evolutionary patterns. We found that the viral sequence appeared stable across the 80km study region, with the exception of the southernmost sampling site, which differed from its nearest neighbour by 7%, despite a geographical separation of only 10km. The southernmost sampling site demonstrated a higher degree of genetic similarity to PUUV previously isolated 100km south thereof; two locations appear to constitute a separate PUUV phylogenetic branch. In contrast to the viral genome, no phylogenetic variance was observed in the bank vole mtDNA in this study. Previous studies have shown that as a result of terrestrial mammals' postglacial re-colonization routes, bank voles and associated PUUV of a southern and a northern lineage established a dichotomous contact zone across the Scandinavian peninsula approximately 100-150km south of the present study sites. Our observations reveal evolutionary divergence of PUUV that has led to dissimilarities within the restricted geographical scale of the northern host re-colonization route as well. These results suggest either a static situation in which PUUV strains are regionally well adapted, or an ongoing process in which strains of PUUV circulate on a geographical scale not yet reliably described.

Place, publisher, year, edition, pages
Elsevier, 2008
National Category
Infectious Medicine
Identifiers
urn:nbn:se:umu:diva-23367 (URN)10.1016/j.meegid.2008.01.003 (DOI)000256289400006 ()18296126 (PubMedID)2-s2.0-43049098969 (Scopus ID)
Available from: 2009-06-13 Created: 2009-06-13 Last updated: 2023-03-24Bibliographically approved
Evander, M., Eriksson, I., Pettersson, L., Juto, P., Ahlm, C., Olsson, G. E., . . . Allard, A. (2007). Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. Journal of Clinical Microbiology, 45(8), 2491-2497
Open this publication in new window or tab >>Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome
Show others...
2007 (English)In: Journal of Clinical Microbiology, ISSN 0095-1137, E-ISSN 1098-660X, Vol. 45, no 8, p. 2491-2497Article in journal (Refereed) Published
Abstract [en]

Puumala virus (PUUV) is the endemic hantavirus in northern Sweden and causes nephropathia epidemica (NE), a milder form of hemorrhagic fever with renal syndrome. There is a need for fast and reliable diagnostics to differentiate the disease from other infections. By aligning virus RNA sequences isolated from 11 different bank voles and one human patient, we designed a real-time reverse transcriptase (RT) PCR method for detection of PUUV RNA. The real-time RT-PCR assay showed linearity from 20 to 2 x 10(6) virus copies with a correlation coefficient above 0.98 to 0.99 for all experiments. The detection threshold for PUUV cDNA was two copies per reaction. A two-step qualitative RT-PCR to detect PUUV RNA showed 100% concordance with the real-time RT-PCR assay. PUUV RNA viremia was detected in 33 of 34 PUUV immunoglobulin M (IgM)-positive patients with typical clinical NE disease from the region of endemicity. One PUUV IgM-negative sample had PUUV RNA, and 4 days later, the patient was IgM positive. Of samples with indeterminate IgM, 43% were PUUV RNA positive. The kinetics of antibody titers and PUUV viremia were studied, and five of six NE patients displayed a decrease in PUUV viremia a few days after disease outbreak coupled with an increase in PUUV IgM and IgG. In one patient with continuously high PUUV RNA levels but low IgM and no IgG response, the infection was lethal. These findings demonstrated that real-time RT-PCR is a useful method for diagnosis of PUUV viremia and for detecting PUUV RNA at early time points, before the appearance of IgM antibodies.

Place, publisher, year, edition, pages
American Society for Microbiology, 2007
National Category
Infectious Medicine
Identifiers
urn:nbn:se:umu:diva-20652 (URN)10.1128/JCM.01902-06 (DOI)17537944 (PubMedID)2-s2.0-34548085701 (Scopus ID)
Available from: 2009-03-24 Created: 2009-03-24 Last updated: 2024-05-07Bibliographically approved
Sundström, P., Juto, P., Wadell, G., Hallmans, G., Svenningsson, A., Nyström, L., . . . Forsgren, L. (2004). An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology, 62(12), 2277-82
Open this publication in new window or tab >>An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study
Show others...
2004 (English)In: Neurology, ISSN 0028-3878, E-ISSN 1526-632X, Vol. 62, no 12, p. 2277-82Article in journal (Refereed) Published
Abstract [en]

Objective: To investigate the association between human herpesviruses and multiple sclerosis (MS), as well as between measles virus and MS.

Methods: The authors identified prospectively collected serum samples from 73 MS cases and retrospective sera from 161 MS cases in two population-based serum bank registers. Analyses of IgG antibody responses in cases and matched referents were performed for Epstein-Barr virus (EBV [EBNA-1 and VCA]), human herpesvirus 6 (HHV-6), herpes simplex virus (HSV), varicella zoster virus (VZV), and measles.

Results: All cases showed signs of past EBV infection. High activity to EBNA-1 and HHV-6 significantly (borderline significance for HHV-6) increased the risk for MS in prospective sera. A discrepancy between activities to EBNA-1 and VCA was striking in MS samples collected less than 5 years before relapsing-remitting MS onset, where high activity to EBNA-1 significantly increased, and high VCA activity significantly decreased the risk for MS. There was no support for major causal roles for HSV, VZV, or measles.

Conclusion: Individuals who will develop MS exhibit an altered immune response against the EBV virus characterized by a high IgG activity to EBNA-1 in the absence of high activity to VCA, this being most pronounced in the 5-year period preceding MS onset.

Place, publisher, year, edition, pages
Aan publication, 2004
Keywords
Adolescent, Adult, Aged, Antigens; Viral/immunology, Capsid Proteins/immunology, Epstein-Barr Virus Infections/*immunology, Epstein-Barr Virus Nuclear Antigens/immunology, Female, Herpesvirus 4; Human/*immunology, Humans, Immunoglobulin G/immunology, Male, Middle Aged, Multiple Sclerosis/*immunology/*virology, Prospective Studies, Retrospective Studies
National Category
Neurology
Identifiers
urn:nbn:se:umu:diva-13772 (URN)10.1212/01.WNL.0000130496.51156.D7 (DOI)15210894 (PubMedID)2-s2.0-2942752168 (Scopus ID)
Available from: 2007-11-23 Created: 2007-11-23 Last updated: 2024-05-07Bibliographically approved
Olsson, G. E., Ahlm, C., Elgh, F., Verlemyr, A.-C., White, N., Juto, P. & Palo, R. T. (2003). Hantavirus antibody occurrence in bank voles (Clethrionomys glareolus) during a vole population cycle. Journal of Wildlife Diseases, 39(2), 299-305
Open this publication in new window or tab >>Hantavirus antibody occurrence in bank voles (Clethrionomys glareolus) during a vole population cycle
Show others...
2003 (English)In: Journal of Wildlife Diseases, ISSN 0090-3558, E-ISSN 1943-3700, Vol. 39, no 2, p. 299-305Article in journal (Refereed) Published
Abstract [en]

Puumala virus, genus Hantavirus, is the etiologic agent of nephropathia epidemica, a mild form of hemorrhagic fever with renal syndrome. The bank vole (Clethrionomys glareolus) is the natural reservoir species of this hantavirus. We initiated sampling of bank voles at sites of recently identified human nephropathia epidemica cases and paired control sites in the fall of 1995 in coastal areas of northern Sweden. Sites were trapped annually in spring and fall until 1999. Prevalence of antibody to Puumala virus was similar among local bank vole populations in the two types of sites over time. During peak years, however, the absolute number of bank voles was higher in case sites than control sites. Consequently, the likelihood of Puumala virus exposure was increased at case sites during population highs. This would imply that the risk of Puumala virus exposure to conspecifics and humans is habitat and site dependent with a temporal component.

Place, publisher, year, edition, pages
Wildlife Disease Association, 2003
Keywords
Bank vole, Clethrionomys glareolus, habitat, hantavirus, nephropathia epidemica, population dynamics, Puumala virus, rodents
National Category
Infectious Medicine
Identifiers
urn:nbn:se:umu:diva-41884 (URN)10.7589/0090-3558-39.2.299 (DOI)12910756 (PubMedID)2-s2.0-0242340241 (Scopus ID)
Available from: 2011-04-01 Created: 2011-04-01 Last updated: 2024-05-07Bibliographically approved
Olsson, G. E., Dalerum, F., Hörnfeldt, B., Elgh, F., Palo, T. R., Juto, P. & Ahlm, C. (2003). Human hantavirus infections, Sweden. Emerging Infectious Diseases, 9(11), 1395-1401
Open this publication in new window or tab >>Human hantavirus infections, Sweden
Show others...
2003 (English)In: Emerging Infectious Diseases, ISSN 1080-6040, E-ISSN 1080-6059, Vol. 9, no 11, p. 1395-1401Article in journal (Refereed) Published
Abstract [en]

The prevalent human hantavirus disease in Sweden is nephropathia epidemica, which is caused by Puumala virus and shed by infected bank voles (Clethrionomys glareolus). To evaluate temporal and spatial patterns of this disease, we studied 2,468 reported cases from a highly disease-endemic region in northern Sweden. We found that, in particular, middle-aged men living in rural dwellings near coastal areas were overrepresented. The case-patients were most often infected in late autumn, when engaged in activities near or within manmade rodent refuges. Of 862 case-patients confident about the site of virus exposure, 50% were concentrated within 5% of the study area. The incidence of nephropathia epidemica was significantly correlated with bank vole numbers within monitored rodent populations in part of the region. Understanding this relationship may help forestall future human hantavirus outbreaks.

Place, publisher, year, edition, pages
Centers for Disease Control and Prevention, 2003
National Category
Public Health, Global Health and Social Medicine
Identifiers
urn:nbn:se:umu:diva-41881 (URN)10.3201/eid0911.030275 (DOI)14718081 (PubMedID)2-s2.0-0242292076 (Scopus ID)
Available from: 2011-04-01 Created: 2011-04-01 Last updated: 2025-02-20Bibliographically approved
Grodzinsky, E., Ivarsson, A., Juto, P., Olcén, P., Fälth-Magnusson, K., Persson, L. A. & Hernell, O. (2001). New automated immunoassay measuring immunoglobulin A antigliadin antibodies for prediction of celiac disease in childhood.. Clinical and diagnostic laboratory immunology, 8(3), 564-570
Open this publication in new window or tab >>New automated immunoassay measuring immunoglobulin A antigliadin antibodies for prediction of celiac disease in childhood.
Show others...
2001 (English)In: Clinical and diagnostic laboratory immunology, ISSN 1071-412X, Vol. 8, no 3, p. 564-570Article in journal (Refereed) Published
Keywords
Adolescent, Antibodies/analysis/*immunology, Celiac Disease/*diagnosis/*immunology, Child, Child; Preschool, Gliadin/*immunology, Humans, Immunoassay/*methods, Immunoglobulin A/immunology, Infant, Predictive Value of Tests, Sensitivity and Specificity
Identifiers
urn:nbn:se:umu:diva-7029 (URN)10.1128/CDLI.8.3.564-570.2001 (DOI)11329459 (PubMedID)
Available from: 2008-01-03 Created: 2008-01-03 Last updated: 2025-10-21Bibliographically approved
Lagerqvist, C., Ivarsson, A., Juto, P., Persson, L. A. & Hernell, O. (2001). Screening for adult coeliac disease - which serological marker(s) to use?. J Intern Med, 250(3), 241-8
Open this publication in new window or tab >>Screening for adult coeliac disease - which serological marker(s) to use?
Show others...
2001 (English)In: J Intern Med, ISSN 0954-6820, Vol. 250, no 3, p. 241-8Article in journal (Refereed) Published
Keywords
Adult, Aged, Celiac Disease/*epidemiology/immunology, Cross-Sectional Studies, Female, Gliadin/immunology, Humans, Immunoglobulin A/*blood, Immunoglobulin G/*blood, Immunoglobulin Isotypes/*blood, Male, Mass Screening, Middle Aged, Sensitivity and Specificity, Transglutaminases/immunology
Identifiers
urn:nbn:se:umu:diva-7030 (URN)11555129 (PubMedID)2-s2.0-0035723338 (Scopus ID)
Available from: 2008-02-01 Created: 2008-02-01 Last updated: 2025-10-21Bibliographically approved
Mincheva-Nilsson, L., Hammarström, M.-L., Juto, P. & Hammarström, S. (1990). Human milk contains proteins that stimulate and suppress T lymphocyte proliferation. Clinical and Experimental Immunology, 79(3), 463-469
Open this publication in new window or tab >>Human milk contains proteins that stimulate and suppress T lymphocyte proliferation
1990 (English)In: Clinical and Experimental Immunology, ISSN 0009-9104, E-ISSN 1365-2249, Vol. 79, no 3, p. 463-469Article in journal (Refereed) Published
Abstract [en]

The modulatory effect of human milk proteins from colostrum and late milk on the proliferative response of human T lymphocytes activated by mitogens (OKT3 and leucoagglutinin from Phaseolus vulgaris) and alloantigens was studied. High concentrations (10-100 micrograms/ml) of crude colostral milk proteins had an inhibitory effect on T cell growth while low concentrations (0.1-1 microgram/ml) enhanced T cells growth. In contrast, proteins from late milk did not inhibit T lymphocyte proliferation while the enhancing effect was retained. Colostrum was fractionated by ammonium sulphate precipitation and gel filtration on sepharose 6B. The inhibitory activity was recovered in a protein fraction containing lactoferrin as its major component. Lactoferrin was, however, not responsible for the observed inhibition. On the contrary, lactoferrin in most cases augmented the proliferative response induced by polyclonal activators. The inhibitory activity was found to bind concanavalin A-sepharose suggesting an association with glycoprotein. Inhibitory fractions contained glycoproteins of the following molecular sizes 26, 74/76 (doublet), 84, 145 and 160 kD under reducing conditions. The inhibitory effect appeared to be lymphocyte specific since the active fraction did not inhibit the growth of tissue culture cells (HeLa cells and human fibroblasts) or bacteria. Furthermore, the fraction was not toxic for lymphocytes. The inhibitory colostrum factor may prevent the newborn from overreacting immunologically against the environmental antigens encountered at birth.

Place, publisher, year, edition, pages
Oxford University Press, 1990
Keywords
inflammatory-bowel-disease, soluble fas ligand, t-cells, ulcerative-colitis, celiac-disease, crohns-disease, regional specialization, immune-system, human gut, expression
National Category
Immunology
Identifiers
urn:nbn:se:umu:diva-67888 (URN)10.1111/j.1365-2249.1990.tb08113.x (DOI)2317950 (PubMedID)
Available from: 2013-04-07 Created: 2013-04-07 Last updated: 2024-07-02Bibliographically approved
Organisations

Search in DiVA

Show all publications